期刊文献+

细菌潜生体与盆腔脓肿发病相关性研究 被引量:6

Study on the association between pelvic abscess and the cryptic growth cell
原文传递
导出
摘要 目的探讨大肠埃希菌潜生体(CGC)的形成机制及其与盆腔脓肿发病的相关性。方法构建盆腔炎性疾病(PID)模型:以雌性SD大鼠为研究对象。开腹在肠系膜处接种大肠埃希菌,观察生殖系统的病理变化,确定PID的急性加重期。构建PID急性加重期模型:分4组,对照组1组,抗生素组3组。注射1/2浓度抗生素,模拟临床非规范化应用。切片观察病灶处病理改变,镜下观察CGC的产生。结果 SD大鼠PID模型病灶处组织病理损伤程度与时间呈正相关。模型中炎症的病理转归分为急性期与慢性期。急性加重期界定为建模后7~17 d,但均无化脓现象。构建PID急性加重期内动物模型,使用1/2浓度头孢菌素的模型组病灶出现化脓反应,组织损伤严重。脓液中检测出革兰阴性、直径3~15μm的纤细大肠埃希菌CGC。结论不规范的抗生素治疗PID可诱导CGC形成,有诱发盆腔脓肿的可能。 Objective To study the antibiotic function of inducing the E.coli to Cryptic Growth Cells(CGC)and its correlation with pelvic abscess.Methods Establish the models of pelvic inflammatory disease(PID);Use the SD female rats as research subjects;inculate the E.coli on the mesosalpinx;observe the pathological changes of reproductive system;determine the acute exacerbation.Establish PID acute exacerbation models and divide them into 4 groups:one for control and the other 3 for experiment.Use 1/2 concentration antibiotics to induce the CGC to simulate denormalized treatment.Observe the pathological change and CGC. Results In the PID models,the pathological change and time had positive correlation.Among these models,the course of PID was divided into acute and chronic stage.The acute exacerbation was defined as the range between 7th to17 th days after modeling,but there was no suppuration during that time.CGC was found from the models which were injected 1/2 concentration of cephalosporins during the acute exacerbation.At the same time,lesions appeared suppuration and serious tissue damage.Conclusion CGC can be induced by nonstandard antibiotic treatment for PID,which may induce pelvic abscess.
出处 《中国实用妇科与产科杂志》 CAS CSCD 北大核心 2017年第3期319-323,共5页 Chinese Journal of Practical Gynecology and Obstetrics
基金 黑龙江省自然科学基金(H2013106)
关键词 盆腔脓肿 细菌潜生体 大肠埃希菌 pelvic abscess cryptic growth cell E. coli
  • 相关文献

参考文献3

二级参考文献84

  • 1夏平光,侯春林,王万宏.几丁糖抑制人成纤维细胞增殖的实验研究[J].中国修复重建外科杂志,2007,21(8):833-836. 被引量:22
  • 2Donders GG,Berger J,Heuninckx H,et al.Vaginal flora chang- es on Pap smears after insertion of levonorgestrel-releasing in- trauterine device[J].Gontracept,2011,83(4):352-356.
  • 3Neale R,Knight I,Keane F.Do users of the intrauterine system(Mirena)have different genital symptoms and vaginal flora than users of the intrauterine contraceptive device?[J].Int J STD AIDS,2009,20(6):423-424.
  • 4Ness RB,Hillier SL,Kip KE,et al.Bacterial vaginosis and risk of pelvic inflammatory disease[J].Obstet Gynecol,2004,104(4):761-769.
  • 5Andrews WW,Hauth JC,Cliver SP,et al.Association of asymp- tomatic bacterial vaginosis with endometrial microbial coloniza- tion and plasma cell endometritis in nonpregnant women[J].Am J Obstet Gynecol,2006,195(6):1611-1616.
  • 6Pham AT,Kives S,Merovitz L,et al.Screening for bacterial vagi- nosis at the time of intrauterine contraceptive device insertion:is there a role?[J].J Obstet Gynaecol Can,2012,34(2):179-185.
  • 7Workowski KA,Bolan GA.Centers for Disease Control and Pre- vention(CDC).Sexually transmitted diseases treatment guide- lines,2015[J].MMWR,2015,64(RR-03):1-137.
  • 8Black A,Francoeur D,Rowe T,et al.SOGC clinical practice guidelines:Canadian contraception consensus[J].J Obstet Gyn- aecol Can,2004,26(3):219-296.
  • 9RCOG.Faculty of sexual and reproductive healthcare clinical ef- fectiveness unit.FSRH guidance(November 2007)intrauterine contraception[Z].London:RCOG,2007.
  • 10World Health Organization.Medical eligibility criteria for con- traceptive use[Z].Geneva:WHO,2009.

共引文献42

同被引文献83

引证文献6

二级引证文献20

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部